171 related articles for article (PubMed ID: 24321259)
1. Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer.
Kowalczyk KJ; Gu X; Nguyen PL; Lipsitz SR; Trinh QD; Lynch JH; Collins SP; Hu JC
Urol Oncol; 2014 Apr; 32(3):303-8. PubMed ID: 24321259
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy.
Kaplan JR; Kowalczyk KJ; Borza T; Gu X; Lipsitz SR; Nguyen PL; Friedlander DF; Trinh QD; Hu JC
BJU Int; 2013 Jun; 111(8):1208-14. PubMed ID: 23551838
[TBL] [Abstract][Full Text] [Related]
3. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.
Briganti A; Wiegel T; Joniau S; Cozzarini C; Bianchi M; Sun M; Tombal B; Haustermans K; Budiharto T; Hinkelbein W; Di Muzio N; Karakiewicz PI; Montorsi F; Van Poppel H
Eur Urol; 2012 Sep; 62(3):472-87. PubMed ID: 22633803
[TBL] [Abstract][Full Text] [Related]
4. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
5. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
Zhou P; Chen MH; McLeod D; Carroll PR; Moul JW; D'Amico AV
J Clin Oncol; 2005 Oct; 23(28):6992-8. PubMed ID: 16192586
[TBL] [Abstract][Full Text] [Related]
6. Morbidity and costs of salvage vs. primary radical prostatectomy in older men.
Prasad SM; Gu X; Kowalczyk KJ; Lipsitz SR; Nguyen PL; Hu JC
Urol Oncol; 2013 Nov; 31(8):1477-82. PubMed ID: 22575240
[TBL] [Abstract][Full Text] [Related]
7. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
8. Survival and secondary interventions following treatment for locally-advanced prostate cancer.
Sussman R; Carvalho FLF; Harbin A; Zheng C; Lynch JH; Stamatakis L; Hwang J; Williams SB; Hu JC; Kowalczyk KJ
Can J Urol; 2018 Oct; 25(5):9516-9524. PubMed ID: 30281010
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification of patients with extraprostatic extension and negative lymph nodes at radical prostatectomy: identifying optimal candidates for adjuvant therapy.
Eisenberg MS; Karnes RJ; Kaushik D; Rangel L; Bergstralh EJ; Boorjian SA
J Urol; 2013 Nov; 190(5):1735-41. PubMed ID: 23727312
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.
Hegarty SE; Hyslop T; Dicker AP; Showalter TN
PLoS One; 2015; 10(2):e0118430. PubMed ID: 25706657
[TBL] [Abstract][Full Text] [Related]
11. A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy.
Budiharto T; Perneel C; Haustermans K; Junius S; Tombal B; Scalliet P; Renard L; Lerut E; Vekemans K; Joniau S; Van Poppel H
Radiother Oncol; 2010 Dec; 97(3):474-9. PubMed ID: 20950879
[TBL] [Abstract][Full Text] [Related]
12. Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
Tsai HK; Chen MH; McLeod DG; Carroll PR; Richie JP; D'Amico AV
Cancer; 2006 Dec; 107(11):2597-603. PubMed ID: 17039498
[TBL] [Abstract][Full Text] [Related]
13. Utilization and expense of adjuvant cancer therapies following radical prostatectomy.
Williams SB; Gu X; Lipsitz SR; Nguyen PL; Choueiri TK; Hu JC
Cancer; 2011 Nov; 117(21):4846-54. PubMed ID: 21365630
[TBL] [Abstract][Full Text] [Related]
14. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
15. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.
Buscariollo DL; Drumm M; Niemierko A; Clayman RH; Galland-Girodet S; Rodin D; Feldman AS; M Dahl D; McGovern FJ; F Olumi A; Eidelman A; Shipley WU; Zietman AL; Efstathiou JA
Pract Radiat Oncol; 2017; 7(2):e125-e133. PubMed ID: 28274403
[TBL] [Abstract][Full Text] [Related]
17. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
Valicenti RK; Chervoneva I; Gomella LG
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.
Porter CR; Capitanio U; Perrotte P; Walz J; Isbarn H; Kodama K; Gibbons RP; Correa R; Karakiewicz PI
BJU Int; 2009 Mar; 103(5):597-602. PubMed ID: 19021603
[TBL] [Abstract][Full Text] [Related]
19. 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer.
Mitchell CR; Boorjian SA; Umbreit EC; Rangel LJ; Carlson RE; Karnes RJ
BJU Int; 2012 Dec; 110(11):1709-13. PubMed ID: 22934913
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]